Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Extraskeletal osteosarcomas in dogs: 14 cases

C A Kuntz1, W S Dernell, B E Powers

  • 1Comparative Oncology Unit, College of Veterinary Medicine and Biomedical Sciences, Colorado State University, Fort Collins 80523, USA.

Journal of the American Animal Hospital Association
|April 4, 1998
PubMed
Summary

Chemotherapy significantly improves survival for dogs with extraskeletal osteosarcomas (EsOSAs). Dogs receiving chemotherapy were less likely to die from their tumors compared to those who did not.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Fibroblastic Subtype has a Favourable Prognosis in Appendicular Osteosarcoma of Dogs.

Journal of comparative pathology·2020
Same author

Immunohistochemical Validation of Spontaneously Arising Canine Osteosarcoma as a Model for Human Osteosarcoma.

Journal of comparative pathology·2017
Same author

DOG1 is a sensitive and specific immunohistochemical marker for diagnosis of canine gastrointestinal stromal tumors.

Journal of veterinary diagnostic investigation : official publication of the American Association of Veterinary Laboratory Diagnosticians, Inc·2015
Same author

Outcome following treatment of soft tissue and visceral extraskeletal osteosarcoma in 33 dogs: 2008-2013.

Veterinary and comparative oncology·2015
Same author

Prognostic significance of histologic features in canine renal cell carcinomas: 70 nephrectomies.

Veterinary pathology·2014
Same author

Elution of antimicrobials from a cross-linked dextran gel: In vivo quantification.

Equine veterinary journal·2012

Area of Science:

  • Veterinary Oncology
  • Canine Cancer Research
  • Surgical Pathology

Background:

  • Extraskeletal osteosarcomas (EsOSAs) are rare malignant bone tumors occurring outside the skeleton.
  • Understanding prognostic factors is crucial for improving outcomes in affected dogs.

Purpose of the Study:

  • To identify prognostic factors for survival in dogs diagnosed with extraskeletal osteosarcomas.
  • To evaluate the impact of chemotherapy on survival rates in canine EsOSAs.

Main Methods:

  • Retrospective case series analysis of fourteen dogs with histopathologically confirmed EsOSAs.
  • Data collection included signalment, tumor primary site, treatment modalities, and survival times.
  • Statistical analysis to identify prognostic indicators for survival.

Related Experiment Videos

Main Results:

  • The median survival time for all dogs was 74 days.
  • The spleen (n=6) and mammary gland (n=3) were the most common primary sites.
  • Chemotherapy was the only significant prognostic factor for survival (p=0.02), with non-chemotherapy cases being 3.62 times more likely to experience tumor-related death.

Conclusions:

  • Chemotherapy demonstrates a significant positive prognostic impact for dogs with extraskeletal osteosarcomas.
  • Further investigation into treatment protocols for canine EsOSAs is warranted.